Hjem › Akut bifenoypisk leukemi › West Virginia
Kliniske studier for Akut bifenoypisk leukemi i West Virginia
3 studier for Akut bifenoypisk leukemi søker deltakere på steder i West Virginia.
Offisiell studietekst (engelsk)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- West Virginia University Charleston Division, Charleston
RekruttererFase 3
365 Days – 25 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- West Virginia University Healthcare, Morgantown
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- West Virginia University Cancer Institute, Morgantown
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT07222579Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.